date:Dec 14, 2022
ation of two strategically complementary companies with a shared purpose and advanced capabilities will show the world the true power of biosolutions, says Ester Baiget, CEO of Novozymes. Todays announcement is fully aligned with Novozymes strategy and is another step toward unlocking additional growth opportunities.
Im proud to share that Novozymes and Chr. Hansen are proposing to join forces to create a Danish-based global biosolutions partner based on our strong complementary technology plat